Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin
- PMID: 8595619
Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin
Abstract
Objectives: To explore the role of blood flow in red blood cell deformability and determine whether it is associated with the release of ATP by red cells.
Methods: A perfusion system was employed to mimic the blood flow conditions. Red cell treatment in vitro with dipyridamole or aspirin, either alone or combined, was performed either on red cells alone prior to blood reconstitution or on already reconstituted blood. Blood viscosity at shear rates of 90 and 450 s-1 was measured, before and after perfusion, by means of a cone/plate viscometer. Red cell deformability was estimated as the magnitude of the slope between these two values of viscosity. ATP level in platelet-free plasma was measured by the firefly luciferase assay, and was used to monitor dipyridamole-induced blockade of ATP efflux by red cells.
Results: In control experiments, red cells became more rigid after perfusion (slope values: 0.62 +/- 0.09 vs 0.40 +/- 0.04; P < 0.05). Absence of platelets or treatment of red cells with aspirin and/or dipyridamole prevented dipyridamole prevented the increased stiffness of red cells observed after exposure of blood to flow conditions. Moreover, a significant increase in red cell deformability was observed when blood was treated with dipyridamole alone or combined with aspirin (0.69 +/- 0.07 and 0.65 +/- 0.05 respectively vs. 0.40 +/- 0.04; P < 0.05). Treatment with dipyridamole alone or combined with aspirin caused a decrease in ATP levels. Statistical significance was reached when red cells alone were treated with dipyridamole alone (45.8 +/- 2.8 vs. 173.3 +/- 47.6 ng ATP/ml; P < 0.05).
Conclusions: Flow stress induced a decrease in red cell deformability probably linked to platelet activation. Treatment with dipyridamole alone or associated with aspirin eliminated the effect of flow, increasing red cell deformability. Under our experimental conditions, modifications could not be ascribed to red cell-released ATP. Our results emphasize the importance of blood flow conditions to evaluate RBC deformability.
Similar articles
-
[Erythrocytes modulate the anti-aggregation effect of aspirin and dipyridamole. Study under static conditions and in a flow system].Sangre (Barc). 1996 Feb;41(1):13-8. Sangre (Barc). 1996. PMID: 8779028 Spanish.
-
Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.J Physiol Pharmacol. 1999 Dec;50(4):629-37. J Physiol Pharmacol. 1999. PMID: 10639013
-
Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.Cardiovasc Res. 1991 Mar;25(3):177-83. doi: 10.1093/cvr/25.3.177. Cardiovasc Res. 1991. PMID: 2029709 Clinical Trial.
-
Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy.Clin Hemorheol Microcirc. 2010;44(3):193-205. doi: 10.3233/CH-2010-1274. Clin Hemorheol Microcirc. 2010. PMID: 20364065 Review.
-
Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.Am J Ther. 2009 Mar-Apr;16(2):164-70. doi: 10.1097/MJT.0b013e31814b17bf. Am J Ther. 2009. PMID: 19300042 Review.
MeSH terms
Substances
LinkOut - more resources
Medical